Sign Up to like & get
recommendations!
0
Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12112760
Abstract: Background: Decision-making and selection of treatment modalities for newly diagnosed prostate cancer (PCa) are often determined by risk stratification using grade group (GG), prostate-specific antigen (PSA), and clinical stage. The discrepancies between needle biopsy (NB)…
read more here.
Keywords:
specimens compared;
group;
radical prostatectomy;
prostatectomy specimens ... See more keywords